Drug Shortage Report for CESAMET
Report ID | 193088 |
Drug Identification Number | 02312263 |
Brand name | CESAMET |
Common or Proper name | CESAMET |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | NABILONE |
Strength(s) | 0.25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | n/a |
ATC code | A04AD |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-07-04 |
Actual start date | |
Estimated end date | 2023-07-07 |
Actual end date | 2023-07-09 |
Shortage status | Resolved |
Updated date | 2023-07-10 |
Company comments | Equipment Related issue |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-07-10 | French | Compare |
v12 | 2023-07-10 | English | Compare |
v11 | 2023-07-05 | English | Compare |
v10 | 2023-06-29 | French | Compare |
v9 | 2023-06-29 | English | Compare |
v8 | 2023-06-27 | English | Compare |
v7 | 2023-06-22 | French | Compare |
v6 | 2023-06-22 | English | Compare |
v5 | 2023-06-17 | English | Compare |
v4 | 2023-05-30 | French | Compare |
v3 | 2023-05-30 | English | Compare |
v2 | 2023-05-25 | French | Compare |
v1 | 2023-05-25 | English | Compare |
Showing 1 to 13 of 13